| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/14/2010 | WO2003064603A9 Nucleic acid molecule encoding iwu-1 |
| 01/14/2010 | US20100010467 Growth hormone releasing hormone treatment to decrease cholesterol levels |
| 01/14/2010 | US20100010229 Fexofenadine polymorph |
| 01/14/2010 | US20100010227 Process for production of piperidine derivatives |
| 01/14/2010 | US20100010222 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient |
| 01/14/2010 | US20100010212 Processes for the preparation of (3R,4S)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe |
| 01/14/2010 | US20100010207 Rna interference mediating small rna molecules |
| 01/14/2010 | US20100010200 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction |
| 01/14/2010 | US20100010100 Dermatological compositions with anti-aging and skin even-toning properties |
| 01/14/2010 | US20100010099 Medium and device for proliferation of stem cells and treatment of cancer-related stem cell with resveratrol |
| 01/14/2010 | US20100010098 Polymorphs of rasagiline hydrochloride |
| 01/14/2010 | US20100010097 Methods for treating mild cognitive impairment and alzheimer's disease |
| 01/14/2010 | US20100010096 Methadone chiral isolate as an improved pharmaceutical |
| 01/14/2010 | US20100010095 Process for purifying rasagiline base |
| 01/14/2010 | US20100010094 Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
| 01/14/2010 | US20100010093 Antiparasitic agents |
| 01/14/2010 | US20100010092 Use of modafinil to treat restless leg syndrome |
| 01/14/2010 | US20100010091 Anhydrous, Dermatological or Cosmetic Preparation Containing Urea |
| 01/14/2010 | US20100010090 Ampa receptor potentiators |
| 01/14/2010 | US20100010088 Compositions and Methods for Prevention and Treatment of Mammalian Diseases |
| 01/14/2010 | US20100010087 Methods for Inducing Stem Cell Migration and Specialization with EC-18 |
| 01/14/2010 | US20100010085 Compositions and Methods for Treating Jellyfish Stings |
| 01/14/2010 | US20100010084 High penetration prodrug compositions of retinoids and retinoid-related compounds |
| 01/14/2010 | US20100010083 Pharmaceutical composition for oral administration |
| 01/14/2010 | US20100010082 Formulations for treating eye disorders |
| 01/14/2010 | US20100010081 Anti-tumor effect of dimeric phthalide compound |
| 01/14/2010 | US20100010080 Use of tylvalosin as antiviral agent |
| 01/14/2010 | US20100010079 Proanthocyanidins for the Treatment of Amyloid and Alpha-Synuclein Diseases |
| 01/14/2010 | US20100010078 Methods of treating androgen dependent prostate cancer by administering an active pharmaceutical ingredient being fisetin, 3,3',4',7-tetrahydroxyflavone or a derivative thereof, in an oral, transdermal or topical dosage form |
| 01/14/2010 | US20100010077 Process for the additivation of wine |
| 01/14/2010 | US20100010076 Macrocyclic Polymorphs, Compositions Comprising Such Polymorphs and Methods of Use and Manufacture Thereof |
| 01/14/2010 | US20100010075 COMPOUNDS FOR ELICITING OR ENHANCING IMMUNE REACTIVITY TO HER-2/neu PROTEIN FOR PREVENTION OR TREATMENT OF MALIGNANCIES IN WHICH THE HER-2/neu ONCOGENE IS ASSOCIATED |
| 01/14/2010 | US20100010074 Inhibiting Serum Response Factor (SRF) to Improve Glycemic Control |
| 01/14/2010 | US20100010072 Microrna biomarkers for human breast and lung cancer |
| 01/14/2010 | US20100010071 Compositions and use of EPAS1 inhibitors |
| 01/14/2010 | US20100010069 Extended Length Borane Phosphonate Nucleic Acid Compounds |
| 01/14/2010 | US20100010068 Liver-directed gene therapy |
| 01/14/2010 | US20100010066 Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene |
| 01/14/2010 | US20100010065 Methods and Compositions for Cellular Reprogramming |
| 01/14/2010 | US20100010064 Cancer treatment by combined inhibition of proteasome and telomerase activities |
| 01/14/2010 | US20100010062 Method of treatment using eprosartan |
| 01/14/2010 | US20100010061 Cb1 receptor modulators |
| 01/14/2010 | US20100010060 Isoindolin-1-One-, Isoindolin-3-One- and Isoindolin-1,3-Dione-Derivatives and Use Thereof |
| 01/14/2010 | US20100010059 Anticancer oral formulation |
| 01/14/2010 | US20100010057 Thiazole derivatives as inhibitors of p13 kinase |
| 01/14/2010 | US20100010056 Treatment for nicotine-induced lung disease using peroxisome proliferator-activated receptor gamma agonists |
| 01/14/2010 | US20100010055 Antagonists of the vanilloid receptor subtype 1 (vr1) and use thereof |
| 01/14/2010 | US20100010054 Therapeutic agent for amyotrophic lateral sclerosis |
| 01/14/2010 | US20100010053 3-[7-(5-{3-Chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-yl]propanoic acid; multiple sclerosis, autoimmune diseases, chronic inflammatory disorders, asthma, inflammatory neuropathies, arthritis, transplantation, Crohn's disease, ulcerative colitis, lupus erythematosis, psoriasis |
| 01/14/2010 | US20100010052 Topical composition comprising a dihydropyridine calcium antagonist |
| 01/14/2010 | US20100010049 Novel Tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof |
| 01/14/2010 | US20100010047 Isotopically substituted proton pump inhibitors |
| 01/14/2010 | US20100010046 Pharmaceutical formulation for parenteral administration |
| 01/14/2010 | US20100010045 PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 01/14/2010 | US20100010044 Novel crystalline form of 2-[4-(4-fluoro-benzyl)-piperidine-1-yl]-2-oxo-n-(2-oxo-2,3-dihydro-benzoxazol-6-yl)-acetamide |
| 01/14/2010 | US20100010043 Percutaneously absorbable preparation |
| 01/14/2010 | US20100010042 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 01/14/2010 | US20100010041 Difluorinated piperidines for treatment of alzheimer's disease and related conditions |
| 01/14/2010 | US20100010040 Triazol Derivatives Useful For The Treatment of Diseases |
| 01/14/2010 | US20100010039 Polymorphic crystal form of a indan-2-ylamino-hydroxyethyl-quinolinone maleate derivative as beta-adrenoceptor agonist |
| 01/14/2010 | US20100010038 Tricyclic compound and pharmaceutical use thereof |
| 01/14/2010 | US20100010037 1h-pyrrolo[2,3-b]pyridine derivatives useful as hsp90 inhibitors |
| 01/14/2010 | US20100010036 Drugs for the treatment of sarcoglycanopathies |
| 01/14/2010 | US20100010035 Novel Dual Action Receptors Antagonists (Dara) at the Ati and Eta Receptors |
| 01/14/2010 | US20100010034 Crth2 antagonists |
| 01/14/2010 | US20100010033 Bis-carbazole DNA intercalating agents for antitumor therapy |
| 01/14/2010 | US20100010032 Camptothecin derivatives with antitumor activity |
| 01/14/2010 | US20100010031 Transoral dosage forms comprising sufentanil and naloxone |
| 01/14/2010 | US20100010030 Extended release hydrocodone acetaminophen and related methods and uses thereof |
| 01/14/2010 | US20100010029 Acute Pain Medications Based on Fast Acting Diclofenac-Opioid Combinations |
| 01/14/2010 | US20100010028 Use of polyols to obtain stable polymorphous forms of rifaximin |
| 01/14/2010 | US20100010027 Abnormal cannabidiols as agents for lowering intraocular pressure |
| 01/14/2010 | US20100010026 Statin and omega-3 fatty acids for reduction of apo-b levels |
| 01/14/2010 | US20100010025 Pyrimidine Derivatives |
| 01/14/2010 | US20100010024 Use of1,4-diaryl-dihydropyrimidine-2-on derivatives for treating pulmonary arterial hypertension |
| 01/14/2010 | US20100010023 Quinazoline derivatives and pharmaceutical compositions containing them |
| 01/14/2010 | US20100010022 Use of pazopanib HCl and lapatinib |
| 01/14/2010 | US20100010021 Novel compounds |
| 01/14/2010 | US20100010020 Phosphodiesterase 4 inhibitors |
| 01/14/2010 | US20100010019 Reactive Oxygen Generating Enzyme Inhibitor With Nitric Oxide Bioactivity and Uses Thereof |
| 01/14/2010 | US20100010018 4-Amino-3-Arylamino-6-Arylpyrazolo[3,4-D) Pyrimidine Derivatives, Methods for their Preparation and their Use as Antiviral Agents |
| 01/14/2010 | US20100010017 Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors |
| 01/14/2010 | US20100010016 Bicyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 01/14/2010 | US20100010015 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 01/14/2010 | US20100010014 Aminopyrimidine compounds and methods of use |
| 01/14/2010 | US20100010013 Dihydropyrimidine compounds and their uses in manufacture of a medicament for treatment and prevention of viral diseases |
| 01/14/2010 | US20100010012 Glutamate aggrecanase inhibitors |
| 01/14/2010 | US20100010011 Compounds that act as a vehicle for delivery through the blood-brain barrier and charge delivery vehicle constructions |
| 01/14/2010 | US20100010010 Hdac inhibitors |
| 01/14/2010 | US20100010009 Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl porteinase inhibitors |
| 01/14/2010 | US20100010008 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/14/2010 | US20100010007 Piperidine derivatives as modulators of chemokine receptor ccr5 |
| 01/14/2010 | US20100010006 Pharmaceutical Combination for and Method of Anesthetizing and Immobilizing Non-Domesticated Mammals |
| 01/14/2010 | US20100010005 Renal Function with Quercetin-Containing Compositions |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100010003 Pyrimidine Derivatives And Their Use As Pesticides |
| 01/14/2010 | US20100010002 Anticancer use of caffeic acid and its derivatives |
| 01/14/2010 | US20100010001 Novel modulators of sphingosine phosphate receptors |
| 01/14/2010 | US20100010000 Amino alcohol derivative and immunosuppresive agent having same as an active ingredient |
| 01/14/2010 | US20100009999 Alkyl substituted indoloquinoxalines |